Key result
Prior treatment with sulfonylureas did not significantly affect long-term survival after acute myocardial infarction in patients with type 2 diabetes compared to other antidiabetic treatments (p=0.53).
Why the study?
Does prior treatment with sulfonylurea drugs affect long-term survival in patients with type 2 diabetes after acute myocardial infarction?
Population
562 patients consecutively admitted to an intensive care unit with the diagnosis of acute myocardial…
Comparison
Sulfonylurea drugs prior to acute myocardial… vs Any other antidiabetic treatment, or no diabetes.
Design
Cohort
Follow-up
> 3 years
Authors
Loading...
No survival difference with prior sulfonylureas; leaves open optimal antidiabetic selection after MI in T2D.
Cohort (n=562)
Does prior treatment with sulfonylurea drugs affect long-term survival in patients with type 2 diabetes after acute myocardial infarction?
p-value: p=0.53
Prior treatment with sulfonylurea drugs does not negatively impact long-term survival after acute myocardial infarction in patients with type 2 diabetes.
Meier et al. (2003) conducted a cohort in Acute myocardial infarction and type 2 diabetes (n=562). Sulfonylureas vs. Any other antidiabetic treatment was evaluated on Long-term survival (p=0.53). Prior treatment with sulfonylureas did not significantly affect long-term survival after acute myocardial infarction in patients with type 2 diabetes compared to other antidiabetic treatments (p=0.53).